Get the latest PGNX - Progenics Pharmaceuticals Inc. stock market performance data and financial news.
Read Jim Cramer's take on Progenics Pharmaceuticals Inc. (PGNX) and get his latest thoughts on the company?s performance and outlook
Get the latest PGNX - Progenics Pharmaceuticals Inc. together with stock market performance data and financial news.
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
Progenics regains worldwide rights to Relistor from Wyeth in a deal that will provide Progenics with $10 million to aid in the transition.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10611187/1/progenics-regains-relistor-rights.html
Progenics regains worldwide rights to Relistor from Wyeth in a deal that will provide Progenics with $10 million to aid in the transition.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10611187/1/progenics-regains-relistor-rights-from-wyeth.html
Shares jump 29% after the company signs a new partner.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10410239/1/tuesdays-winners-losers-cell-genesys.html
News that the drug had been OK'd pushed shares significantly higher.. Check out TheStreet for the latest stock market news and financial investment headlines.
How the Glaxo buy of Sirtris fits a recent mould; reading into Spectrum Pharma's data for ozarelix.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10413329/1/biotech-notebook-glaxo-wyeth-spectrum.html
Here'a a quick round-up of non-ImClone related news from this weekend's American Society of Clinical Oncology meeting.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10419286/1/asco-a-biotech-scorecard.html
Connect with TheStreet